Oaktree Acquisition Corp. III Life Sciences
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|
| – | +30,456.0% | +1.0% | +1.0% | +1.0% | +0.9% | +0.8% | +0.8% | |
| – | – | -4.9% | +5.3% | -5.1% | +4.5% | -8.5% | -11.0% | |
| – | – | -5.6% | +8.1% | -4.1% | +8.0% | -11.0% | -7.6% | |
| – | – | -5.6% | +8.1% | -4.1% | +8.0% | -11.0% | -7.6% | |
| – | +1,069.9% | +4.3% | +0.8% | +1.3% | +0.9% | +3.9% | +1.2% | |
| – | +9.9% | +45.5% | +5.7% | +9.6% | +5.9% | +25.0% | +6.5% | |
| – | -89.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | -3.6% | +8.5% | +21.2% | +49.7% | +4.1% | |
| – | – | +0.9% | +1.0% | +1.0% | +0.9% | +0.7% | +0.8% | |
| – | – | – | – | – | – | – | – | |
| – | +9.6% | +0.0% | +0.0% | -21.9% | +28.0% | -21.9% | +0.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.